Kusajili – Clinical trials directory

Result of your search per sponsor: Pfizer Inc. 235 East 42nd street – New York – 10017 NY - USA

Woman and Man Max 99 years
Pfizer Inc. 235 East 42nd street – New York – 10017 NY - USA Update Il y a 4 ans

A RANDOMIZED, PHASE 3 STUDY OF SUNITINIB IN COMBINATION WITH CAPECITABINE COMPARED WITH CAPECITABINE IN PATIENTS WITH PREVIOUSLY TREATED BREAST CANCER To demonstrate that the combination of sunitinib plus capecitabine is superior to capecitabine monotherapy in prolonging the progression-free survival (PFS) for ABC patients

Country None
organs None
Specialty None

unknown

More information